A young mum who received lifesaving cancer treatment in Manchester has welcomed a “miracle” baby after fearing she may be infertile.
26-year-old Sammy Gray nearly died from cancer three years ago not long after welcoming her first child, but after receiving pioneering CAR-T therapy to save her life at The Christie NHS Foundation Trust in Manchester, she has welcomed her second child and is believed to be one of the first patients in the UK to give birth following the innovative treatment that “cleared her body of cancer”.
Sammy said that if it wasn’t for the treatment and expert care she received at The Christie, “neither of us would be here now.”
Back in January 2018, shortly after Sammy had her first daughter Harper, she began to experience chest pains and night sweats that doctors initially thought could have been due to a blood clot related to the birth, but they later discovered a mass on her chest, which lead to a devastating diagnosis of non Hodgkin’s lymphoma – a type of cancer that develops in the lymphatic system.
Sammy, then just 21, sadly “missed out on motherhood” as she underwent a range of chemotherapy and radiotherapy treatments, which were initially shrinking the tumour.
ADVERTISEMENT
But the cancer unfortunately became more aggressive and progressed.
By June 2019, when faced with a very poor prognosis, Sammy’s only remaining option was CAR-T therapy – a new treatment only approved by the NHS in 2018 that involves reprogramming the patient’s own immune cells, called T cells, which are then used to recognise and destroy their cancer.
ADVERTISEMENT
Sammy Gray received pioneering CAR-T therapy at The Christie NHS Foundation Trust / Credit: The Christie NHS Foundation Trust
Sammy underwent the gruelling therapy back in September 2019 – which involved her having to spend weeks in hospital while her body’s own immune system attacked the cancer, and unfortunately made her very ill in the process.
“I wasn’t petrified of dying, but I was petrified of leaving Harper behind,” Sammy explained.
“It has been an incredibly tough few years and I missed out on so much of my first taste of motherhood when Harper was a baby as the chemotherapy made me very ill, so I couldn’t look after my baby daughter, and Daley, my fiancé, had to be a full-time dad.”
ADVERTISEMENT
Thankfully though, the treatment was successful, and her scans at three, six, and 12 months were all clear and showed no signs of cancer.
Although, Sammy then faced a different challenge.
Doctors warned that the chemotherapy could have resulted in early menopause, meaning she may not be able to have more children, and after not having periods for a year, she did fear she’d become infertile – but as Sammy and her partner desperately wanted a second child to complete their family, she was approved by the NHS for IVF fertility treatment.
The couple had just started the process when they conceived naturally, and two and half years after she endured the CAR-T treatment, the couple welcomed their baby son, Walter, back in February.
Sammy and her partner Daley welcomed their “miracle” baby son, Walter, back in February / Credit: Kelly Couttie Photography
“I’m determined to make the most of every minute with Walter,” Sammy continued.
ADVERTISEMENT
“The sleepless nights don’t bother me at all, and I appreciate all the little things. I’m enjoying the time with him that cancer stole with Harper. Walter is our little miracle.
“If it wasn’t for the CAR-T treatment at The Christie, neither of us would be here now.”
Speaking on Sammy’s incredible recovery, Professor Adrian Bloor – Consultant Haematologist at The Christie – added: “Sammy’s cancer was very difficult to treat and there were very few treatment options.
“CAR-T therapy is a relatively new treatment for some aggressive blood cancers, where the patient’s immune cells are ‘trained’ to fight the cancer, [and] Sammy was one of our first CAR-T patients, and at that time the youngest.
ADVERTISEMENT
“The treatment saved her life and it’s fantastic that she remains in remission and has had a baby.
“We all wish her and her family all the best for the future.”
Canadian performer Tate McRae is bringing her viral bangers to Co-op Live, Manchester for a night of sass, synths and of course dance breaks.
The time has come to let all your ‘exes’ know, put your ‘Sports car’ in drive and get ready to ‘run for the hills’ because it’s finally time for Tate McRae to take to the Co-op Live stage in Manchester.
Now the Calgary-born talent, four albums deep and only 21 years old, is ready to perform to 23,500 Manchester fans at our city’s largest indoor entertainment venue.
Tate McRae gig guide
Tate McRae is visiting Manchester twice, 24 May and 25 June, playing Co-op Live.
Sun 22 June – Nottingham, UK – Nottingham Motorpoint Arena
Tue 24 June – London, UK – The O2 Arena
Thu 25 June – Manchester, UK – Co-op Live
Tate McRae tickets for Co-op Live gig
‘What would you do?’ if I told you that there were tickets left for Tate McRae’s Co-op Live shows in Manchester, because there just might be.
Any fans of this Canadian pop star will have to act fast because there are only a select number of precious tickets left for both of her Manchester dates.
Tickets for both Tate McRae’s shows on Saturday, 24 May and Thursday, 25 June, are selling fast and are in high demand.
What are the stage times for Tate McRae in Manchester?
Co-op Live has a strict curfew of 11pm meaning the Canadian performer might have her set wrapped up before the clock hits ’10:35′.
Anyone attending can expect the doors to open at 6:30pm with a kick-off time of 8pm and support from New Zealand star BENEE, best known for soundtracking lockdown with her huge hit, ‘Supalonely’, collaborating with the likes of Gus Dapperton, Spacey Jane and more.
For those of you heading to Co-op Live, you’ll be glad to know it’s right next door to a rather famous big blue stadium and its integrated Metrolink stop.
Head along the light blue or orange lines directly to the Etihad Campus or Ashton-under-Lyne, and you can get off the tram literally spitting distance from the arena. You can find the full map HERE.
Trams run frequently on the Ashton-Eccles line to the Etihad stop, with services leaving every six minutes from the city centre and until 1:00am on Fridays and Saturdays.
Bus
You can find the full list of bus routes HERE, with the one in closest proximity to the venue being the 53 bus, which runs from Cheetham Hill through to Higher Crumpsall, Old Trafford and Pendleton, leaving just a two-minute walk to Co-op Live. You also get free Bee Network travel with any valid event ticket.
Getting there by car and parking
If you’re driving, there is limited parking available at the venue, but this must be pre-booked ahead of time, and there are designated drop-off areas.
The postcode is M11 3DU and you can follow the signs towards the wider Etihad Campus as you get closer; directions to the adjacent drop-off points will also be signposted.
Keep in mind that congestion on the roads close to the stadium is expected to gather around two hours prior to any event, so if you are travelling on the road, these are the suggested times they provide come event day, though estimates will obviously vary:
Alan Turing Way (both directions): plan an additional 20 minutes into any journey by road.
Hyde Road (eastbound): expect an additional 15 minutes to be added to your journey.
Mancunian Way (westbound): plan for an extra 10 minutes of travel time.
There are also three park-and-ride facilities near Co-op Live, but be advised that the Velopark and Holt Town stops will be closed post-event to help safely manage crowds:
Ashton West (Ashton line) – 184 spaces and 11 disabled spaces
Ladywell (Ashton-Eccles line) – 332 spaces and 22 disabled spaces
Walk/cycle
Lastly, Co-op Live is only a half-hour stroll from Manchester Piccadilly, and you could even walk along the canal all the way to the front door if you fancy taking the scenic route.
Greater Manchester now also offers the option to hire bikes through the Beryl, with riders able to locate, unlock, get to their destination and then safely lock up the bike all through an easy-to-use app. There are hire points just near the south-west corner of the Etihad Stadium on Ashton New Road.
For more information on all travel options, you can check out the enhanced journey planner.
ADVERTISEMENT
Expect nothing but hits from 21 year old superstar Tate McRae when she performs at Co-op Live, Manchester.
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”